BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3990723)

  • 1. Verapamil concentrations in cerebrospinal fluid after oral administration.
    Doran AR; Narang PK; Meigs CY; Wolkowitz OM; Roy A; Breier A; Pickar D
    N Engl J Med; 1985 May; 312(19):1261-2. PubMed ID: 3990723
    [No Abstract]   [Full Text] [Related]  

  • 2. Steady-state cerebrospinal fluid transfer of verapamil and metabolites in patients with schizophrenia.
    Narang PK; Blumhardt CL; Doran AR; Pickar D
    Clin Pharmacol Ther; 1988 Nov; 44(5):550-7. PubMed ID: 3180637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics and pharmacodynamics of verapamil in healthy volunteers after single oral and sublingual administration].
    Woodcock BG; Wörner P; Rietbrock N; Schwabe L; Frömming KH
    Arzneimittelforschung; 1982; 32(12):1567-71. PubMed ID: 6891597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.
    Krecic-Shepard ME; Barnas CR; Slimko J; Schwartz JB
    Clin Pharmacol Ther; 2000 Sep; 68(3):286-92. PubMed ID: 11014410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of S-verapamil after single doses of two different galenic formulations of racemic verapamil.
    Harder S; Siewert M; Thürmann P; Blume H; Rietbrock N; Siewert B
    Arzneimittelforschung; 1993 May; 43(5):520-2. PubMed ID: 8328995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
    Fromm MF; Busse D; Kroemer HK; Eichelbaum M
    Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PQ-intervals and serum concentrations as indices of verapamil absorption following sublingual, buccal and per oral administration in man.
    Woodcock BG; Asthana OP; Wenchel M; Rietbrock N
    Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):537-41. PubMed ID: 6664153
    [No Abstract]   [Full Text] [Related]  

  • 8. Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans.
    Schwarz UI; Gramatté T; Krappweis J; Berndt A; Oertel R; von Richter O; Kirch W
    Clin Pharmacol Ther; 1999 Mar; 65(3):283-90. PubMed ID: 10096260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil disposition and effect on PQ-intervals after buccal, oral and intravenous administration.
    Asthana OP; Woodcock BG; Wenchel M; Frömming KH; Schwabe L; Rietbrock N
    Arzneimittelforschung; 1984; 34(4):498-502. PubMed ID: 6540109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil stereoisomerism: enantiomeric ratios in plasma dependent on peak concentrations, oral input rate, or both.
    Karim A; Piergies A
    Clin Pharmacol Ther; 1995 Aug; 58(2):174-84. PubMed ID: 7648767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
    Chen M; Xu D; Hu XL; Wang H
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral verapamil for angina pectoris.
    Med Lett Drugs Ther; 1982 Jun; 24(611):56-8. PubMed ID: 7087888
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.
    Piao YJ; Choi JS
    Arch Pharm Res; 2008 Apr; 31(4):518-22. PubMed ID: 18449511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the enantiomers of verapamil in the dog.
    Bai SA; Lankford SM; Johnson LM
    Chirality; 1993; 5(6):436-42. PubMed ID: 8398603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of naringin on the pharmacokinetics of verapamil and one of its metabolites, norverapamil, in rabbits.
    Kim HJ; Choi JS
    Biopharm Drug Dispos; 2005 Oct; 26(7):295-300. PubMed ID: 16013069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A suicide attempt with oral verapamil: a case report].
    Rodríguez Blanco VM; Rodríguez Suárez ML; Möller Bustinza I; Castellanos Martínez E; Puebla Rojo V; Barriales Alvarez V; Cortina Llosa A
    Rev Esp Cardiol; 1993 Dec; 46(12):837-9. PubMed ID: 8134697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil metabolite exposure in older and younger men during steady-state oral verapamil administration.
    Abernethy DR; Wainer IW; Anacleto AI
    Drug Metab Dispos; 2000 Jul; 28(7):760-5. PubMed ID: 10859149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trials of auricular defibrillation with the quinidine-verapamil combination by oral route].
    De Soldati L; Stritzler G; Balassanian S; Fuksman A; Mario Krasnov C; Rosental R; Chutlian A; Fabregas R
    Prensa Med Argent; 1972 May; 59(17):665-70. PubMed ID: 5048460
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats.
    Choi DH; Chang KS; Hong SP; Choi JS; Han HK
    Biopharm Drug Dispos; 2008 Jan; 29(1):45-50. PubMed ID: 17941000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiogenic shock following a single therapeutic oral dose of verapamil.
    Stajer D; Bervar M; Horvat M
    Int J Clin Pract; 2001; 55(1):69-70. PubMed ID: 11219325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.